
Novo Integrated Sciences, Inc.: management transactions · United States · SEC (Form 4)
SEC:novo-integrated-sciences-inc-0fa583USUS·SEC (Form 4)Mcap 1267.8Bn€Healthcare
Browse the full management transaction log of Novo Integrated Sciences, Inc., a listed issuer based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Novo Integrated Sciences, Inc. has published 1 insider filings. Market capitalisation: €1,267.8bn. The latest transaction was disclosed on 21 April 2022 (Acquisition). Among the most active insiders: Oliva Robert Letterio. The full history is accessible without an account.
Financial data
FY ended December 2025 · cache
Analyst consensus
23 analysts175.00 €Target 307.99 €(+8%)444.00 €
Income statement
Revenue309.06 Bn€
Gross profit250.28 Bn€81% margin
Net income102.43 Bn€37.2% margin
Valuation
PER (trailing)10.4x
PER (forward)13.4x
P/Book6.3x
Beta0.35
Balance sheet & cash
Market cap1267.80 Bn€
Total debt130.96 Bn€
Free Cash Flow28.99 Bn€
Debt / Equity72%
Profitability & ownership
ROE71.4%
ROA19.2%
% insiders5.3%
% institutions30.7%
Last declaration on 21 April 2022